<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34181102</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-6293</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Current neurology and neuroscience reports</Title><ISOAbbreviation>Curr Neurol Neurosci Rep</ISOAbbreviation></Journal><ArticleTitle>The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>44</StartPage><MedlinePgn>44</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">44</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11910-021-01130-1</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global health challenge. This review aims to summarize the incidence, risk factors, possible pathophysiology, and proposed management of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC) or neuro-PASC based on the published literature.</AbstractText><AbstractText Label="RECENT FINDINGS">The National Institutes of Health has noted that PASC is a multi-organ disorder ranging from mild symptoms to an incapacitating state that can last for weeks or longer following recovery from initial infection with SARS-CoV-2. Various pathophysiological mechanisms have been proposed as the culprit for the development of PASC. These include, but are not limited to, direct or indirect invasion of the virus into the brain, immune dysregulation, hormonal disturbances, elevated cytokine levels due to immune reaction leading to chronic inflammation, direct tissue damage to other organs, and persistent low-grade infection. A multidisciplinary approach for the treatment of neuro-PASC will be required to diagnose and address these symptoms. Tailored rehabilitation and novel cognitive therapy protocols are as important as pharmacological treatments to treat neuro-PASC effectively. With recognizing the growing numbers of COVID-19 patients suffering from neuro-PASC, there is an urgent need to identify affected individuals early to provide the most appropriate and efficient treatments. Awareness among the general population and health care professionals about PASC is rising, and more efforts are needed to understand and treat this new emerging challenge. In this review, we summarize the relevant scientific literature about neuro-PASC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moghimi</LastName><ForeName>Narges</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Napoli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurological Service, SS Annunziata Hospital, Sulmona, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biller</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegler</LastName><ForeName>James E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Cooper Neurological Institute, Cooper University Health Care, Camden, NJ, 08103, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shekhar</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCullough</LastName><ForeName>Louise D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Department of Neurology, McGovern Medical School, University of Texas Health Sciences Center, Houston, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harkins</LastName><ForeName>Michelle S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, University of New Mexico, Albuquerque, NM, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alaouieh</LastName><ForeName>Danielle A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansueto</LastName><ForeName>Gelsomina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, University of Campania, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Divani</LastName><ForeName>Afshin A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Neurology, School of Medicine, 1 University of New Mexico, MSC10-5620, Albuquerque, NM, 87131, USA. adivani@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Neurol Neurosci Rep</MedlineTA><NlmUniqueID>100931790</NlmUniqueID><ISSNLinking>1528-4042</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Post-Acute Sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Narges Moghimi, Mario Di Napoli, Jos&#xe9; Biller, James E. Siegler, Rahul Shekhar, Louise D McCullough, Michelle S Harkins, Emily Hong, Danielle A Alaouieh, Gelsomina Mansueto, and Afshin A. Divani each declare no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>28</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34181102</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pii">10.1007/s11910-021-01130-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, Gao L, Ge MQ, Hung IFN, Ip MSM, Ip P, Lau KK, Lau CS, Lau LKW, Leung WK, Li X, Luo H, Man KKC, Ng VWS, Siu CW, Wan EYF, Wing YK, Wong CSM, Wong KHT, Wong ICK. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9(1):2190&#x2013;2199. doi: 10.1080/22221751.2020.1825914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1825914</ArticleId><ArticleId IdType="pmc">PMC7586446</ArticleId><ArticleId IdType="pubmed">32940572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansueto G. COVID-19: brief check through the pathologist&#x2019;s eye (autopsy archive) Pathol Res Pract. 2020;216(11):153195. doi: 10.1016/j.prp.2020.153195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2020.153195</ArticleId><ArticleId IdType="pmc">PMC7452828</ArticleId><ArticleId IdType="pubmed">32890939</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020. 10.1136/thoraxjnl-2020-216,086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Per&#xe9;z O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Inf Secur. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis. 2020;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2020.104941</ArticleId><ArticleId IdType="pmc">PMC7214348</ArticleId><ArticleId IdType="pubmed">32689643</ArticleId></ArticleIdList></Reference><Reference><Citation>Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9. doi: 10.1007/s11910-021-01102-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01102-5</ArticleId><ArticleId IdType="pmc">PMC7882462</ArticleId><ArticleId IdType="pubmed">33586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Divani AA, Andalib S, Biller J, Di Napoli M, Moghimi N, Rubinos CA, et al. Central nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2020;20(12):60. doi: 10.1007/s11910-020-01079-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-020-01079-7</ArticleId><ArticleId IdType="pmc">PMC7599061</ArticleId><ArticleId IdType="pubmed">33128130</ArticleId></ArticleIdList></Reference><Reference><Citation>YMJ G, Van Herck M, Delbressine JM, Vaes AW, Meys R, FVC M, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4). 10.1183/23120541.00542-2020In previously hospitalized and non-hospitalized patients with confirmed or suspected COVID-19, multiple symptoms were present about 3 months after symptoms onset.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;long haulers&#x201d; stump experts. JAMA. 2020;324:1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020. 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, Sheill G, Dyer AH, O&#x2019;Kelly B, Hynes JP, Mooney A, Dunne J, Ni Cheallaigh C, O&#x2019;Farrelly C, Bourke NM, Conlon N, Martin-Loeches I, Bergin C, Nadarajan P, Bannan C. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18:997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020:2020.12.24.20248802. doi:10.1101/2020.12.24.20248802.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;32. 10.1016/S0140-6736(20)32656-8At 6 months after acute infection, COVID-19 survivors mainly suffered from fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations and were the main target population for the long-term recovery intervention.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, Flament T, Ferreira-Maldent N, Bruy&#xe8;re F, Stefic K, Gaudy-Graffin C, Grammatico-Guillon L, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Inf Secur. 2020;81(6):e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3(1):25. doi: 10.1186/1472-6963-3-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-3-25</ArticleId><ArticleId IdType="pmc">PMC317472</ArticleId><ArticleId IdType="pubmed">14702202</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327&#x2013;338. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosen A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229. doi: 10.3389/fimmu.2018.00229.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00229</ArticleId><ArticleId IdType="pmc">PMC5818468</ArticleId><ArticleId IdType="pubmed">29497420</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Katz BZ, Fernandes H, Fletcher MA, Klimas N, Smith FA, O&#x2019;Gorman MRG, Vernon SD, Taylor R. Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med. 2012;10:191. doi: 10.1186/1479-5876-10-191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-10-191</ArticleId><ArticleId IdType="pmc">PMC3480896</ArticleId><ArticleId IdType="pubmed">22973830</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss-Morris R, Deary V, Castell B. Chronic fatigue syndrome. Handb Clin Neurol. 2013;110:303&#x2013;314. doi: 10.1016/B978-0-444-52901-5.00025-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-52901-5.00025-3</ArticleId><ArticleId IdType="pubmed">23312650</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinde B. Is chronic fatigue syndrome caused by a rare brain infection of a common, normally benign virus? Med Hypotheses. 2008;71(2):270&#x2013;274. doi: 10.1016/j.mehy.2008.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2008.03.014</ArticleId><ArticleId IdType="pubmed">18440157</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB. Historical Insight into Infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit. 2021;27:e931447. doi: 10.12659/MSM.931447.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.931447</ArticleId><ArticleId IdType="pmc">PMC7924007</ArticleId><ArticleId IdType="pubmed">33633106</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985;102(1):1&#x2013;7. doi: 10.7326/0003-4819-102-1-.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-102-1-</ArticleId><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A, Dubbo Infection Outcomes Study Group Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. doi: 10.1136/bmj.38933.585764.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, et al. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol. 2010;91(Pt 4):893&#x2013;897. doi: 10.1099/vir.0.017590-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.017590-0</ArticleId><ArticleId IdType="pubmed">20007355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, Pape J, Reeves WC, Campbell GL. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol. 2008;2(2):477&#x2013;499. doi: 10.1348/174866407x218312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/174866407x218312</ArticleId><ArticleId IdType="pubmed">19824176</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61(1):43&#x2013;48. doi: 10.1136/jcp.2007.050054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2007.050054</ArticleId><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, Bleeker-Rovers CP. Fatigue following acute Q-fever: a systematic literature review. PLoS One. 2016;11(5):e0155884. doi: 10.1371/journal.pone.0155884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0155884</ArticleId><ArticleId IdType="pmc">PMC4880326</ArticleId><ArticleId IdType="pubmed">27223465</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006;37(Suppl 1):S39&#x2013;S46. doi: 10.1016/S1386-6532(06)70010-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(06)70010-5</ArticleId><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1&#x2013;6. doi: 10.1016/j.jcv.2006.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.10.011</ArticleId><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-ebola signs and symptoms in U.S. survivors. N Engl J Med. 2015;373(25):2484&#x2013;2486. doi: 10.1056/NEJMc1506576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1506576</ArticleId><ArticleId IdType="pubmed">26672870</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolson GL, Gan R, Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111(5):557&#x2013;566. doi: 10.1034/j.1600-0463.2003.1110504.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2003.1110504.x</ArticleId><ArticleId IdType="pubmed">12887507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. 1990;88(6):577&#x2013;581. doi: 10.1016/0002-9343(90)90520-n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(90)90520-n</ArticleId><ArticleId IdType="pubmed">2346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Litleskare S, Rortveit G, Eide GE, Hanevik K, Langeland N, Wensaas KA. Prevalence of irritable bowel syndrome and chronic fatigue 10 years after giardia infection. Clin Gastroenterol Hepatol. 2018;16(7):1064&#x2013;1072. doi: 10.1016/j.cgh.2018.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2018.01.022</ArticleId><ArticleId IdType="pubmed">29378314</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, Bateman L, DeMaria A, Jr, Lapp CW, Rowe PC, Proskauer C. Estimating prevalence, demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018;6:412. doi: 10.3389/fped.2018.00412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00412</ArticleId><ArticleId IdType="pmc">PMC6331450</ArticleId><ArticleId IdType="pubmed">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J Transl Med. 2020;18(1):100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, AS B, Gaini S, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020. 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, So WY, Fong SY, Lam SP. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P, Gunnes N, Tveito K, Bakken IJ, Ghaderi S, Stoltenberg C, Hornig M, Lipkin WI, Trogstad L, H&#xe5;berg SE. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312&#x2013;1320. doi: 10.1001/archinte.167.12.1312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y, Ma X, Zhan F, Wang L, Hu T, Zhou H, Hu Z, Zhou W, Zhao L, Chen J, Meng Y, Wang J, Lin Y, Yuan J, Xie Z, Ma J, Liu WJ, Wang D, Xu W, Holmes EC, Gao GF, Wu G, Chen W, Shi W, Tan W. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics (Basel). 2019;9(3). 10.3390/diagnostics9030080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787592</ArticleId><ArticleId IdType="pubmed">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(12):841&#x2013;850. doi: 10.7326/M15-0114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-0114</ArticleId><ArticleId IdType="pubmed">26075755</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O&#x2019;Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. 2020;11:826. doi: 10.3389/fneur.2020.00826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K, Scheibenbogen C. A Unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): recognitions from the finding of autoantibodies against ss2-adrenergic receptors. Autoimmun Rev. 2020;19(6):102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11(24):4017&#x2013;4020. doi: 10.1021/acschemneuro.0c00725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman S, Morris MC, Broderick G, Craddock TJA, Klimas NG, Fletcher MA. Pharmaceutical Interventions in chronic fatigue syndrome: a literature-based commentary. Clin Ther. 2019;41(5):798&#x2013;805. doi: 10.1016/j.clinthera.2019.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.02.011</ArticleId><ArticleId IdType="pmc">PMC6543846</ArticleId><ArticleId IdType="pubmed">30871727</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Hardcastle SL, Atkinson GM, van Driel ML, Kreijkamp-Kaspers S, Ashton KJ, Staines DR, Marshall-Gradisnik SM. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights. 2013;4(3):69&#x2013;80. doi: 10.1007/s13317-013-0051-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13317-013-0051-x</ArticleId><ArticleId IdType="pmc">PMC4389023</ArticleId><ArticleId IdType="pubmed">26000145</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley AS, Ford B, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol. 2013;172(1):73&#x2013;80. doi: 10.1111/cei.12043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12043</ArticleId><ArticleId IdType="pmc">PMC3719933</ArticleId><ArticleId IdType="pubmed">23480187</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff JM, King EC, Lee JS, Sepulveda N, Wolf AS, Kingdon C, et al. Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front Immunol. 2019;10:796. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, Chu L, Younger JW, Tato CM, Davis MM. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017;114(34):E7150&#x2013;E71E8. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Freitag H, Blanco J, Capelli E, Lacerda E, Authier J, Meeus M, Castro Marrero J, Nora-Krukle Z, Oltra E, Strand EB, Shikova E, Sekulic S, Murovska M. The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE. J Transl Med. 2017;15(1):162. doi: 10.1186/s12967-017-1263-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1263-z</ArticleId><ArticleId IdType="pmc">PMC5530475</ArticleId><ArticleId IdType="pubmed">28747192</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther OP, Gardy JL, Stafford P, Fluge O, Mella O, Tang P, et al. Immunosignature analysis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Mol Neurobiol. 2019;56(6):4249&#x2013;4257. doi: 10.1007/s12035-018-1354-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1354-8</ArticleId><ArticleId IdType="pmc">PMC6505503</ArticleId><ArticleId IdType="pubmed">30298340</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, Huber M, Klimas NG, Lee B, Lee H, Levine S, Montoya JG, Peterson DL, Komaroff AL, Lipkin WI. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS. PLoS One. 2020;15(7):e0236148. doi: 10.1371/journal.pone.0236148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236148</ArticleId><ArticleId IdType="pmc">PMC7373296</ArticleId><ArticleId IdType="pubmed">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson DL, Knox KK, Schultz AF, Eddy ML, Che X, Lipkin WI. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. 2016;21(2):261&#x2013;269. doi: 10.1038/mp.2015.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.29</ArticleId><ArticleId IdType="pubmed">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. 2008;101(12):961&#x2013;965. doi: 10.1093/qjmed/hcn123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, et al. Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome. J Intern Med. 2017;281(2):179&#x2013;188. doi: 10.1111/joim.12564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12564</ArticleId><ArticleId IdType="pubmed">27696568</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J Transl Med. 2020;18(1):7. doi: 10.1186/s12967-019-02196-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02196-9</ArticleId><ArticleId IdType="pmc">PMC6943902</ArticleId><ArticleId IdType="pubmed">31906979</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. doi: 10.1038/s41421-020-0168-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0168-9</ArticleId><ArticleId IdType="pmc">PMC7197635</ArticleId><ArticleId IdType="pubmed">32377375</ArticleId></ArticleIdList></Reference><Reference><Citation>Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 2021;22(4):404&#x2013;411. doi: 10.1038/s41590-021-00901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00901-9</ArticleId><ArticleId IdType="pmc">PMC9317654</ArticleId><ArticleId IdType="pubmed">33723418</ArticleId></ArticleIdList></Reference><Reference><Citation>Unamuno X, Gomez-Ambrosi J, Rodriguez A, Becerril S, Fruhbeck G, Catalan V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Investig. 2018;48(9):e12997. doi: 10.1111/eci.12997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12997</ArticleId><ArticleId IdType="pubmed">29995306</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Voort PHJ, Moser J, Zandstra DF, Muller Kobold AC, Knoester M, Calkhoven CF, Hamming I, van Meurs M. Leptin levels in SARS-CoV-2 infection related respiratory failure: a cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon. 2020;6(8):e04696. doi: 10.1016/j.heliyon.2020.e04696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e04696</ArticleId><ArticleId IdType="pmc">PMC7439829</ArticleId><ArticleId IdType="pubmed">32844126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu Y, Zhang X, Wang S, Peng Z, Guo J, et al. Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol. 2021. 10.1002/JLB.5HI1020-704R.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10016867</ArticleId><ArticleId IdType="pubmed">33404078</ArticleId></ArticleIdList></Reference><Reference><Citation>Demidowich AP, Levine JA, Apps R, Cheung FK, Chen J, Fantoni G, et al. Colchicine&#x2019;s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. Int J Obes. 2020;44(8):1793&#x2013;1799. doi: 10.1038/s41366-020-0598-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0598-3</ArticleId><ArticleId IdType="pmc">PMC7253147</ArticleId><ArticleId IdType="pubmed">32461554</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164&#x2013;1177. doi: 10.1182/bloodadvances.2020003568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003568</ArticleId><ArticleId IdType="pmc">PMC7908851</ArticleId><ArticleId IdType="pubmed">33635335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Phys Cell Phys. 2021;320(1):C57&#x2013;C65. doi: 10.1152/ajpcell.00426.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00426.2020</ArticleId><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, Eaton-Fitch N, Staines D, Marshall-Gradisnik S. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID) J Transl Med. 2020;18(1):198. doi: 10.1186/s12967-020-02356-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02356-2</ArticleId><ArticleId IdType="pmc">PMC7222338</ArticleId><ArticleId IdType="pubmed">32404171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenwood BM, Weaver JL, Bajwa A, Poon IK, Byrne FL, Murrow BA, Calderone JA, Huang L, Divakaruni AS, Tomsig JL, Okabe K, Lo RH, Cameron Coleman G, Columbus L, Yan Z, Saucerman JJ, Smith JS, Holmes JW, Lynch KR, Ravichandran KS, Uchiyama S, Santos WL, Rogers GW, Okusa MD, Bayliss DA, Hoehn KL. Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metab. 2014;3(2):114&#x2013;123. doi: 10.1016/j.molmet.2013.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmet.2013.11.005</ArticleId><ArticleId IdType="pmc">PMC3953706</ArticleId><ArticleId IdType="pubmed">24634817</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567&#x2013;595. doi: 10.1146/annurev-immunol-073119-095439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-073119-095439</ArticleId><ArticleId IdType="pmc">PMC7190443</ArticleId><ArticleId IdType="pubmed">32017655</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21(4):e49799. doi: 10.15252/embr.201949799.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949799</ArticleId><ArticleId IdType="pmc">PMC7132203</ArticleId><ArticleId IdType="pubmed">32202065</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2021:gutjnl-2021-324090. 10.1136/gutjnl-2021-324090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944&#x2013;955. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res. 2020;30(4):299&#x2013;315. doi: 10.1007/s10286-020-00714-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00714-0</ArticleId><ArticleId IdType="pmc">PMC7374073</ArticleId><ArticleId IdType="pubmed">32700055</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, Huq S, Khalafallah AM, Koenecke A, Xiong R, Mensh B, Papadopoulos N, Kinzler KW, Vogelstein B, Vogelstein JT, Athey S, Zhou S, Bettegowda C. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists. J Clin Invest. 2020;130(7):3345&#x2013;3347. doi: 10.1172/JCI139642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139642</ArticleId><ArticleId IdType="pmc">PMC7324164</ArticleId><ArticleId IdType="pubmed">32352407</ArticleId></ArticleIdList></Reference><Reference><Citation>Staedtke V, Bai RY, Kim K, Darvas M, Davila ML, Riggins GJ, Rothman PB, Papadopoulos N, Kinzler KW, Vogelstein B, Zhou S. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 2018;564(7735):273&#x2013;277. doi: 10.1038/s41586-018-0774-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0774-y</ArticleId><ArticleId IdType="pmc">PMC6512810</ArticleId><ArticleId IdType="pubmed">30542164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J. 2017;51(5):243&#x2013;247. doi: 10.1080/14017431.2017.1355068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14017431.2017.1355068</ArticleId><ArticleId IdType="pubmed">28738696</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Chan JF, Yuen TT, Shuai H, Yuan S, Wang Y, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1(1):e14&#x2013;e23. doi: 10.1016/S2666-5247(20)30004-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30004-5</ArticleId><ArticleId IdType="pmc">PMC7173822</ArticleId><ArticleId IdType="pubmed">32835326</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, Liu SS, Zhang NN, Li XF, Xiong R, Guo Y, Deng YQ, Huang WJ, Liu Q, Liu QM, Shen YL, Zhou Y, Yang X, Zhao TY, Fan CF, Zhou YS, Qin CF, Wang YC. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 2020;28(1):124&#x2013;133. doi: 10.1016/j.chom.2020.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu YF, Gong HR, Lee ACY, Zou Z, Yau T, Wu W, Hung IFN, Chan JFW, Yuen KY, Huang JD. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30(10):928&#x2013;931. doi: 10.1038/s41422-020-0390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. 2020;68(2):251&#x2013;252. doi: 10.1007/s12020-020-02325-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType="pmc">PMC7186765</ArticleId><ArticleId IdType="pubmed">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin Endocrinol. 2005;63(2):197&#x2013;202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, Warnke C. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268(2):392&#x2013;402. doi: 10.1007/s00415-020-10067-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10067-3</ArticleId><ArticleId IdType="pmc">PMC7370630</ArticleId><ArticleId IdType="pubmed">32691236</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health &amp; Behavior. 2020;8(2):61&#x2013;69. doi: 10.1080/21641846.2020.1778227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573&#x2013;580. doi: 10.1021/acschemneuro.0c00793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LZ, Wang S. Prevalence and predictors of general psychiatric disorders and loneliness during COVID-19 in the United Kingdom. Psychiatry Res. 2020;291:113267. doi: 10.1016/j.psychres.2020.113267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113267</ArticleId><ArticleId IdType="pmc">PMC7326403</ArticleId><ArticleId IdType="pubmed">32623266</ArticleId></ArticleIdList></Reference><Reference><Citation>Orgiles M, Morales A, Delvecchio E, Mazzeschi C, Espada JP. Immediate psychological effects of the COVID-19 quarantine in youth from Italy and Spain. Front Psychol. 2020;11:579038. doi: 10.3389/fpsyg.2020.579038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2020.579038</ArticleId><ArticleId IdType="pmc">PMC7677301</ArticleId><ArticleId IdType="pubmed">33240167</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond) 2020;57:236&#x2013;243. doi: 10.1016/j.amsu.2020.07.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2020.07.054</ArticleId><ArticleId IdType="pmc">PMC7403130</ArticleId><ArticleId IdType="pubmed">32802325</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G. Immunosenescence exacerbates the COVID-19. Arch Gerontol Geriatr. 2020;90:104174. doi: 10.1016/j.archger.2020.104174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2020.104174</ArticleId><ArticleId IdType="pmc">PMC7333612</ArticleId><ArticleId IdType="pubmed">32653765</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, Wu J, du H, Chen T, Li R, Tan H, Kang L, Yao L, Huang M, Wang H, Wang G, Liu Z, Hu S. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. doi: 10.1001/jamanetworkopen.2020.3976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.3976</ArticleId><ArticleId IdType="pmc">PMC7090843</ArticleId><ArticleId IdType="pubmed">32202646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanardo V, Manghina V, Giliberti L, Vettore M, Severino L, Straface G. Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynaecol Obstet. 2020;150(2):184&#x2013;188. doi: 10.1002/ijgo.13249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijgo.13249</ArticleId><ArticleId IdType="pmc">PMC9087548</ArticleId><ArticleId IdType="pubmed">32474910</ArticleId></ArticleIdList></Reference><Reference><Citation>Dresler M, Sandberg A, Bublitz C, Ohla K, Trenado C, Mroczko-Wasowicz A, et al. Hacking the brain: dimensions of cognitive enhancement. ACS Chem Neurosci. 2019;10(3):1137&#x2013;1148. doi: 10.1021/acschemneuro.8b00571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00571</ArticleId><ArticleId IdType="pmc">PMC6429408</ArticleId><ArticleId IdType="pubmed">30550256</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T. Assessment and management of post-COVID fatigue. Progress in Neurology and Psychiatry. 2021;25(1):36&#x2013;39. doi: 10.1002/pnp.698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pnp.698</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther. 2020;12(1):170. doi: 10.1186/s13195-020-00744-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00744-w</ArticleId><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet N Long COVID: understanding the neurological effects. The Lancet Neurology. 2021;20(4):247. doi: 10.1016/S1474-4422(21)00059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00059-4</ArticleId><ArticleId IdType="pmc">PMC7969137</ArticleId><ArticleId IdType="pubmed">33743226</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Helbok R, Crean M, Chou SH, McNett M, Moro E, et al. The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19. Eur J Neurol. 2020. 10.1111/ene.14652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753513</ArticleId><ArticleId IdType="pubmed">33220127</ArticleId></ArticleIdList></Reference><Reference><Citation>Helbok R, Chou SH, Beghi E, Mainali S, Frontera J, Robertson C, Fink E, Schober M, Moro E, McNett M, Bassetti CL, GCS-NeuroCOVID consortium. EAN COVID task force NeuroCOVID: it&#x2019;s time to join forces globally. Lancet Neurol. 2020;19(10):805&#x2013;806. doi: 10.1016/S1474-4422(20)30322-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30322-7</ArticleId><ArticleId IdType="pmc">PMC7494307</ArticleId><ArticleId IdType="pubmed">32949535</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. doi: 10.1016/j.jns.2020.116884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116884</ArticleId><ArticleId IdType="pmc">PMC7204734</ArticleId><ArticleId IdType="pubmed">32464367</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251-2. doi:10.1001/jama.2020.22717.</Citation><ArticleIdList><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kampen JJA, van de Vijver D, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat Commun. 2021;12(1):267. doi: 10.1038/s41467-020-20568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-20568-4</ArticleId><ArticleId IdType="pmc">PMC7801729</ArticleId><ArticleId IdType="pubmed">33431879</ArticleId></ArticleIdList></Reference><Reference><Citation>Stormorken E, Jason LA, Kirkevold M. Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults&#x2019; experiences. BMC Public Health. 2017;17(1):952. doi: 10.1186/s12889-017-4968-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-017-4968-2</ArticleId><ArticleId IdType="pmc">PMC5729235</ArticleId><ArticleId IdType="pubmed">29237442</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, O'Connor L, Leavy D, O'Brien K, Dowds J, Sugrue JA, Hopkins D, Martin-Loeches I, Ni Cheallaigh C, Nadarajan P, McLaughlin AM, Bourke NM, Bergin C, O'Farrelly C, Bannan C, Conlon N. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne) 2020;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreh E, Jacobs JM, Stessman J. Fatigue, function, and mortality in older adults. J Gerontol A Biol Sci Med Sci. 2010;65(8):887&#x2013;895. doi: 10.1093/gerona/glq064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glq064</ArticleId><ArticleId IdType="pubmed">20418349</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576&#x2013;590. doi: 10.1038/s41574-018-0059-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-018-0059-4</ArticleId><ArticleId IdType="pubmed">30046148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. doi: 10.1136/bmj.m1198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1198</ArticleId><ArticleId IdType="pubmed">32217618</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US influenza vaccine effectiveness network 2012-2013. Clin Infect Dis. 2016;62(4):448&#x2013;455. doi: 10.1093/cid/civ952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/civ952</ArticleId><ArticleId IdType="pmc">PMC4725387</ArticleId><ArticleId IdType="pubmed">26565004</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez M, Jaundoo R, Hilton K, Del Alamo A, Gemayel K, Klimas NG, et al. Genetic predisposition for immune system, hormone, and metabolic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. Front Pediatr. 2019;7:206. doi: 10.3389/fped.2019.00206.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00206</ArticleId><ArticleId IdType="pmc">PMC6542994</ArticleId><ArticleId IdType="pubmed">31179255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cope H, David A, Pelosi A, Mann A. Predictors of chronic &#x201c;postviral&#x201d; fatigue. Lancet. 1994;344(8926):864&#x2013;868. doi: 10.1016/s0140-6736(94)92833-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(94)92833-9</ArticleId><ArticleId IdType="pubmed">7916407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Katz BZ, Shiraishi Y, Mears CJ, Im Y, Taylor R. Predictors of post-infectious chronic fatigue syndrome in adolescents. Health Psychol Behav Med. 2014;2(1):41&#x2013;51. doi: 10.1080/21642850.2013.869176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21642850.2013.869176</ArticleId><ArticleId IdType="pmc">PMC3956649</ArticleId><ArticleId IdType="pubmed">24660116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubun K, Nemoto K, Oka H, Fukuda H, Yamakawa Y, Watanabe Y. Association of fatigue and stress with gray matter volume. Front Behav Neurosci. 2018;12:154. doi: 10.3389/fnbeh.2018.00154.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2018.00154</ArticleId><ArticleId IdType="pmc">PMC6066525</ArticleId><ArticleId IdType="pubmed">30087602</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1). 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalin A, Javid B, Knight M, Inada-Kim M, Greenhalgh T. Direct and indirect evidence of efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: a rapid systematic review. Syst Rev. 2021;10(1):77. doi: 10.1186/s13643-021-01620-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-021-01620-w</ArticleId><ArticleId IdType="pmc">PMC7961172</ArticleId><ArticleId IdType="pubmed">33726854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantha S, Tripuraneni SL, Roizen MF, Fleisher LA. Proposed modifications in the 6-Minute Walk Test for potential application in patients with mild COVID-19: a step to optimize triage guidelines. Anesth Analg. 2020;131(2):398&#x2013;402. doi: 10.1213/ANE.0000000000004986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004986</ArticleId><ArticleId IdType="pmc">PMC7258841</ArticleId><ArticleId IdType="pubmed">32433249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, Bonini I, Koch G, Saltuari L, Quartarone A, Oliviero A, Kofler M, Versace V. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci. 2021;420:117271. doi: 10.1016/j.jns.2020.117271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117271</ArticleId><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O&#x2019;Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949&#x2013;959. doi: 10.1136/bjsports-2020-102596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2020-102596</ArticleId><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman KJ, Murovska M, Pheby DFH, Zalewski P. Our Evolving Understanding of ME/CFS. Medicina (Kaunas). 2021;57(3). 10.3390/medicina57030200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J Transl Med. 2020;18(1):289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: individual and societal costs. Dyn Med. 2008;7:6. doi: 10.1186/1476-5918-7-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-5918-7-6</ArticleId><ArticleId IdType="pmc">PMC2324078</ArticleId><ArticleId IdType="pubmed">18397528</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): where will the drugs come from? Pharmacol Res. 2021;165:105465. doi: 10.1016/j.phrs.2021.105465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie IB, Wilson AJ, Wright JM, Bennett BK, Wakefield D, Lloyd AR. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry. 2000;61(9):643&#x2013;648. doi: 10.4088/jcp.v61n0909.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/jcp.v61n0909</ArticleId><ArticleId IdType="pubmed">11030484</ArticleId></ArticleIdList></Reference><Reference><Citation>Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med. 2006;119(2):167 e23&#x2013;167 e30. doi: 10.1016/j.amjmed.2005.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.07.047</ArticleId><ArticleId IdType="pubmed">16443425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser JD. A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome. Int J Clin Exp Med. 2015;8(7):11064&#x2013;11074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565289</ArticleId><ArticleId IdType="pubmed">26379906</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C, Henle W. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med. 1988;319(26):1692&#x2013;1698. doi: 10.1056/NEJM198812293192602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198812293192602</ArticleId><ArticleId IdType="pubmed">2849717</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WM. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) Expert Rev Clin Pharmacol. 2016;9(6):755&#x2013;770. doi: 10.1586/17512433.2016.1172960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2016.1172960</ArticleId><ArticleId IdType="pmc">PMC4917909</ArticleId><ArticleId IdType="pubmed">27045557</ArticleId></ArticleIdList></Reference><Reference><Citation>Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, Lapp CW, Peterson DL, the Chronic Fatigue Syndrome AMP-516 Study Group. Mitchell WM. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7(3):e31334. doi: 10.1371/journal.pone.0031334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0031334</ArticleId><ArticleId IdType="pmc">PMC3303772</ArticleId><ArticleId IdType="pubmed">22431963</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, Bredie SJH, Heijnen M, Dinarello CA, Knoop H, Van der Meer JWM. Cytokine inhibition in patients with chronic fatigue syndrome: a randomized trial. Ann Intern Med. 2017;166(8):557&#x2013;564. doi: 10.7326/m16-2391.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/m16-2391</ArticleId><ArticleId IdType="pubmed">28265678</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, et al. B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS One. 2015;10(7):e0129898. doi: 10.1371/journal.pone.0129898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129898</ArticleId><ArticleId IdType="pmc">PMC4488509</ArticleId><ArticleId IdType="pubmed">26132314</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekeland IG, Fossa A, Lande A, Ktoridou-Valen I, Sorland K, Holsen M, et al. Intravenous cyclophosphamide in myalgic encephalomyelitis/chronic fatigue syndrome. An Open-Label Phase II Study. Front Med (Lausanne) 2020;7:162. doi: 10.3389/fmed.2020.00162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00162</ArticleId><ArticleId IdType="pmc">PMC7201056</ArticleId><ArticleId IdType="pubmed">32411717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare AJ, Heap E, Malhi GS, Wessely S, O&#x2019;Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 1999;353(9151):455&#x2013;458. doi: 10.1016/S0140-6736(98)04074-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)04074-4</ArticleId><ArticleId IdType="pubmed">9989716</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie R, O&#x2019;Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA. 1998;280(12):1061&#x2013;1066. doi: 10.1001/jama.280.12.1061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.280.12.1061</ArticleId><ArticleId IdType="pubmed">9757853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans L, Nijs J, Calders P, De Clerck L, Moorkens G, Hans G, et al. Influence of morphine and naloxone on pain modulation in rheumatoid arthritis, chronic fatigue syndrome/fibromyalgia, and controls: a double-blind, randomized, placebo-controlled, cross-over study. Pain Pract. 2018;18(4):418&#x2013;430. doi: 10.1111/papr.12613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/papr.12613</ArticleId><ArticleId IdType="pubmed">28722815</ArticleId></ArticleIdList></Reference><Reference><Citation>Boomershine CS. Pregabalin for the management of fibromyalgia syndrome. J Pain Res. 2010;3:81&#x2013;88. doi: 10.2147/jpr.s7884.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/jpr.s7884</ArticleId><ArticleId IdType="pmc">PMC3004647</ArticleId><ArticleId IdType="pubmed">21197312</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, Segundo MJ, Saez-Francas N, Calvo N, Roman-Malo L, et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015;22(8):679&#x2013;685. doi: 10.1089/ars.2014.6181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.6181</ArticleId><ArticleId IdType="pmc">PMC4346380</ArticleId><ArticleId IdType="pubmed">25386668</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolle M, Freitag H, Antelmann M, Hartwig J, Schuchardt M, van der Giet M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: efficacy of repeat immunoadsorption. J Clin Med. 2020;9(8). 10.3390/jcm9082443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465279</ArticleId><ArticleId IdType="pubmed">32751659</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Saez-Francas N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174(5):345&#x2013;369. doi: 10.1111/bph.13702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. NICE backtracks on graded exercise therapy and CBT in draft revision to CFS guidance. BMJ. 2020;371:m4356. doi: 10.1136/bmj.m4356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4356</ArticleId><ArticleId IdType="pubmed">33172928</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021:1&#x2013;18. 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Zhou X, Liu H, Hashimoto K. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders. Br J Psychiatry. 2020;217(1):351. doi: 10.1192/bjp.2020.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2020.84</ArticleId><ArticleId IdType="pmc">PMC7190394</ArticleId><ArticleId IdType="pubmed">32270760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>